- Home
- SVA vs SXC Comparison
SVA vs SXC Comparison
Compare SVA & SXC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SVA
- SXC
- Stock Information
- Founded
- SVA N/A
- SXC 1960
- Country
- SVA
- SXC United States
- Employees
- SVA 3261
- SXC N/A
- Industry
- SVA
- SXC Steel/Iron Ore
- Sector
- SVA
- SXC Industrials
- Exchange
- SVA NYSE
- SXC Nasdaq
- Market Cap
- SVA N/A
- SXC N/A
- IPO Year
- SVA N/A
- SXC N/A
- Fundamental
- Price
- SVA $6.47
- SXC $8.17
- Analyst Decision
- SVA
- SXC Strong Buy
- Analyst Count
- SVA 0
- SXC 1
- Target Price
- SVA N/A
- SXC $12.00
- AVG Volume (30 Days)
- SVA N/A
- SXC 886.1K
- Earning Date
- SVA N/A
- SXC 10-30-2024
- Dividend Yield
- SVA N/A
- SXC 5.88%
- EPS Growth
- SVA N/A
- SXC N/A
- EPS
- SVA N/A
- SXC 0.73
- Revenue
- SVA N/A
- SXC $2,000,300,000.00
- Revenue This Year
- SVA N/A
- SXC N/A
- Revenue Next Year
- SVA N/A
- SXC N/A
- P/E Ratio
- SVA N/A
- SXC $11.13
- Revenue Growth
- SVA N/A
- SXC N/A
- 52 Week Low
- SVA N/A
- SXC $8.05
- 52 Week High
- SVA N/A
- SXC $11.85
- Technical
- Relative Strength Index (RSI)
- SVA N/A
- SXC 31.04
- Support Level
- SVA N/A
- SXC $8.67
- Resistance Level
- SVA N/A
- SXC $9.11
- Average True Range (ATR)
- SVA 0.00
- SXC 0.24
- MACD
- SVA 0.00
- SXC -0.00
- Stochastic Oscillator
- SVA 0.00
- SXC 11.74
About SVA SINOVAC BIOTECH LTD
Sinovac Biotech Ltd is a China-based biopharmaceutical company that focuses on research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases including, without limitation, hepatitis A, hepatitis B, hand foot and mouth disease (HFMD) caused by EV71, seasonal influenza, H5N1 and H1N1 pandemic influenza, coronavirus, pneumococcus, poliomyelitis, varicella and mumps.